Stonepine Capital, L.P.

Stonepine Capital, L.P. discloses dealings in 5 companies, chiefly Apollo Endosurgery, Inc., Novelion Therapeutics Inc. and QLT Inc/BC. Over a trading history stretching from 24 November 2015 to 5 August 2021, the count stands at 26 filings.

The open-market side counts 22 purchases for €4.6M alongside 2 sales for €2.0M. On balance, insiders were net buyers of €2.6M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

In size, the median ticket on the buying side is €42k. None of the 21 purchases we analysed coincided with buying by another insider of the same company within 30 days.

The newest entry dates from 9 August 2021: a transaction, in Chiasma, Inc. The latest purchase dates back some time: it was published 2,508 days ago, on 12 December 2019. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.